CA
NZ
UK
AU
IND
US
Alaunos Therapeutics, Inc. (Nasdaq:TCRT) has priced a registered direct offering, agreeing to sell 380,469 shares of common stock alongside pre-funded warrants covering up to an additional 386,654 shares. The offering price of $1.46 per share was set at-the-market underNasdaqrules, and the transaction is expected …
Halozyme Therapeutics, Inc. (Nasdaq:HALO) has priced 1.3 billion dollars in aggregate principal amount of convertible senior notes due 2033, carrying a 1.50% annual interest rate. The offering size was increased from an originally announced 1.05 billion dollars, with initial purchasers also granted an option …
BlossomHill Therapeutics, Inc. (Nasdaq:BLSM), a clinical-stage oncology company, has reported financial results for the second quarter of 2026, its first as a publicly traded company following an initial public offering completed in August. The IPO generated approximately 168.3 million dollars in gross proceeds through …
XORTX Therapeutics Inc. (NASDAQ:XRTX), a late-stage clinical pharmaceutical company, has outlined plans to submit an Investigational New Drug application to the FDA in the fourth quarter of 2026 for its XRx-026 gout program. The filing represents a defined step in the company's broader strategy …
Corcept Therapeutics Incorporated (NASDAQ:CORT) has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use, recommending that the European Commission approve relacorilant, marketed as Lifyorli, in combination with nab-paclitaxel chemotherapy for platinum-resistant ovarian cancer. The recommendation moves the …
Alkermes (NASDAQ:ALKS) shares fell sharply in Friday's session, sharply underperforming the broader healthcare sector, which has been relatively firm amid a market rebound following the Federal Reserve's rate decision. Alkermes is a fully integrated, Dublin, Ireland-headquartered biopharmaceutical company that develops, manufactures, and commercializes medicines …
Alamar Biosciences (NASDAQ:ALMR) shares extended their multi-day rally in Friday's session, trading near their 52-week high, as momentum continues to build following last month's standout second-quarter earnings report. Alamar Biosciences is a Fremont, California-based commercial-stage proteomics company that has developed a proprietary Precision Proteomics …
bioAffinity Technologies (NASDAQ:BIAF) shares climbed sharply in Friday's session after the Hong Kong Intellectual Property Department granted a patent covering the company's proprietary platform technology for predicting the likelihood of lung cancer using flow cytometry and fluorescent markers in sputum. bioAffinity Technologies is a …
AbbVie Inc. (NYSE:ABBV) has presented new observational data for VRAYLAR, its cariprazine-based psychiatric therapy, at Psych Congress 2026. The presentation included results from two prospective real-world studies, one in bipolar I depression and another in major depressive disorder, alongside pediatric safety findings and comparative …
DataMeds AI, Inc. (NASDAQ:MEDS), formerly known as Wellgistics Health, has resolved litigation connected to outstandingDebtand receivables tied to a May 2023 membership purchase interest agreement. The dispute had previously resulted in liabilities of approximately 19 million dollars being carried on the company's balance sheet.
Please wait processing your request...